Home › U. of Utah, Intermountain Win $3.8M Grant to Develop Cancer Risk Management Platform

U. of Utah, Intermountain Win $3.8M Grant to Develop Cancer Risk Management Platform

Sep 01, 2017

NEW YORK (360Dx) – A team of researchers from the University of Utah, Intermountain Healthcare, and the Huntsman Cancer Institute have received a five-year, $3.8 million grant from the National Cancer Institute to develop a platform for personalized cancer risk management.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
26
Featured Webinar

The Landscape of Alternative Polyadenylation in the Lung Cancer Transcriptome

Sponsored by
Lexogen

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.

Jul
10
Featured Webinar

Case Study: Genetic Testing Lab Sees 25-Fold Scaleup with New Informatics System

Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Jul
19
Featured Webinar

Advances in NGS for Ultra-High Sensitivity Applications in Translational and Clinical Research

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

What's Popular?

In Molecular Diagnostics

  1. Roche to Acquire Outstanding Shares of Foundation Medicine for $2.4B

  2. Mayo Team Describes Clinical RNA Sequencing Assay for Oncogenic Fusions

    Premium

  3. Myriad Genetics Submits Supplementary PMA for BRACAnalysis CDx

  4. Merck KGaA Advancing Tepotinib in MET-Altered Cancer Subpopulations

    Premium

  5. Cigna to Cover GenomeDx's Decipher Prostate Cancer Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.